About
Our Story
Leadership
Research Partners
Our Science
ImmuX Technology
FusionX Technology
IME Cell Technology
R&D Pipeline
Publications
Media
Careers
Contact
About
Our Story
Leadership
Research Partners
Our Science
ImmuX Technology
FusionX Technology
IME Cell Technology
R&D Pipeline
Publications
Media
Careers
Contact
中文
English
Media
CD Biopharma CEO, Dr. Xu, to Attend Bio International 2025
CD Biopharma CEO, Dr. Xu, to Attend Bio International 2025
CD Biopharma CEO, Dr. Xu, to Attend Bio International 2025
2025-06-10
08:00:00
SUZHOU, China – CD (Suzhou) Biopharma today announced that Alan Xu, PhD, Chief Executive Officer, wi...
SUZHOU, China – CD (Suzhou) Biopharma today announced that Alan Xu, PhD, Chief Executive Officer, wi...
SUZHOU, China – CD (Suzhou) Biopharm...
CD Biopharma Presented Key CD-001 Program Results at AACR 2025
CD Biopharma Presented Key CD-001 Program Results at AACR 2025
CD Biopharma Presented Key CD-001 Program Results at AACR 2025
2025-05-06
21:00:00
CD (Suzhou) Biopharma is pleased to announce that CEO Dr. Jian Xu recently participated in the prest...
CD (Suzhou) Biopharma is pleased to announce that CEO Dr. Jian Xu recently participated in the prest...
CD (Suzhou) Biopharma is pleased to ...
CD-001 Receives NMPA Approval to Initiate Clinical Trials in Hematologic Malignancies
CD-001 Receives NMPA Approval to Initiate Clinical Trials in Hematologic Malignancies
CD-001 Receives NMPA Approval to Initiate Clinical Trials in Hematologic Malignancies
2025-03-13
14:29:19
Suzhou, China, March 11, 2025 – CD (Suzhou) Biopharma today announced that its lead investigational ...
Suzhou, China, March 11, 2025 – CD (Suzhou) Biopharma today announced that its lead investigational ...
Suzhou, China, March 11, 2025 – CD (...
CD Biopharma Achieves First Patient Dosing Milestone for Lead Program CD-001
CD Biopharma Achieves First Patient Dosing Milestone for Lead Program CD-001
CD Biopharma Achieves First Patient Dosing Milestone for Lead Program CD-001
2025-01-20
17:18:00
SUZHOU, China, January 20, 2025 - CD (Suzhou) Biopharma announced that it has successfully dosed the...
SUZHOU, China, January 20, 2025 - CD (Suzhou) Biopharma announced that it has successfully dosed the...
SUZHOU, China, January 20, 2025 - CD...
Exciting News | CD Biopharma's CD-001 Study Initiates at Lead Clinical Site
Exciting News | CD Biopharma's CD-001 Study Initiates at Lead Clinical Site
Exciting News | CD Biopharma's CD-001 Study Initiates at Lead Clinical Site
2025-01-06
13:00:00
SUZHOU, China, January 6, 2025 - CD (Suzhou) Biopharma announces that its CD-001-CT101 study was off...
SUZHOU, China, January 6, 2025 - CD (Suzhou) Biopharma announces that its CD-001-CT101 study was off...
SUZHOU, China, January 6, 2025 - CD ...
1
2
Next
Total 2 Page
To
Page
Sure
